Cargando…
c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice
CD44 isoforms act as coreceptors for the receptor tyrosine kinases c-Met and VEGFR-2. However, Cd44 knockout mice do not show overt phenotypes, in contrast to Met and Vegfr-2 knockout mice. We hypothesized that CD44 is being compensated for by another factor in Cd44 null mice. Using RNAi technology...
Autores principales: | Olaku, Vivienne, Matzke, Alexandra, Mitchell, Claudia, Hasenauer, Susanne, Sakkaravarthi, Arul, Pace, Giuseppina, Ponta, Helmut, Orian-Rousseau, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145552/ https://www.ncbi.nlm.nih.gov/pubmed/21680714 http://dx.doi.org/10.1091/mbc.E11-02-0134 |
Ejemplares similares
-
Internalization of Met Requires the Co-Receptor CD44v6 and Its Link to ERM Proteins
por: Hasenauer, Susanne, et al.
Publicado: (2013) -
Correction: Internalization of Met Requires the Co-Receptor CD44v6 and Its Link to ERM Proteins
por: Hasenauer, Susanne, et al.
Publicado: (2013) -
CD44 regulates Wnt signaling at the level of LRP6
por: Orian-Rousseau, Véronique, et al.
Publicado: (2015) -
CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
por: Li, Linxian, et al.
Publicado: (2016) -
CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis
por: Orian-Rousseau, Véronique
Publicado: (2015)